BIO-key International Inc. (NASDAQ:BKYI) Shares Shorted: Short Interest Up 14,917.0% in September

BIO-key International Inc. (NASDAQ:BKYI) saw a large increase in short interest in September. As of September 30th, there was short interest totaling 995,329 shares, an increase of 14,917.0% from the September 15th total of 6,628 shares. Approximately 72.2% of the company’s shares are short sold. Based on an average daily volume of 15,350,267 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a report on Friday, July 17th. Zacks Research raised shares of BIO-key International to a “hold” rating in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce”.

BIO-key International Stock Down 4.0%

Shares of BKYI stock traded down $0.07 during mid-day trading on Friday, hitting $1.67. 79,324 shares of the company’s stock were exchanged, compared to its average volume of 1,039,427. The stock has a market cap of $2.40 million, a price-to-earnings ratio of -0.41 and a beta of 0.50. BIO-key International has a fifty-two week low of $1.61 and a fifty-two week high of $19.70. The stock has a 50-day simple moving average of $2.91 and a two-hundred day simple moving average of $4.20.

BIO-key International (NASDAQ:BKYI) last released its earnings results on Thursday, August 13th. The technology company reported ($0.56) EPS for the quarter, beating the consensus estimate of ($0.82) by $0.26. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%.The firm had revenue of $1.92 million during the quarter, compared to analyst estimates of $1.80 million. As a group, analysts anticipate that BIO-key International will post -1.62 earnings per share for the current fiscal year.

About BIO-key International

BIO-key International, Inc (NASDAQ: BKYI) develops biometric identity and access-management solutions. Its technology enables organizations to authenticate users through fingerprints and other biometric credentials, helping replace or supplement passwords while supporting secure access to applications, networks and devices.

The company’s offerings include biometric readers and software, as well as identity and access-management platforms such as PortalGuard and WEB-key. These products are designed to support multifactor authentication, single sign-on, password management and identity verification across on-premises and cloud-based environments.

BIO-key serves businesses, government agencies, educational institutions and other organizations that require secure user authentication.